prikaz prve stranice dokumenta Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
  Download
PDF 518.8 KB
Scientific paper - Original scientific paper
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
Expert Review of Pharmacoeconomics & Outcomes Research, 16 (2015), 5; 609-618. https://doi.org/10.1586/14737167.2016.1115347
Marković-Peković, Vanda; Škrbić, Ranko; Petrović, Aleksandar; Vlahović-Palčevski, Vera; Mrak, Jana; Bennie, Marion; Fadare, Joseph; Kwon, Hye-Young; Schiffers, Krijn; Truter, Ilse; Godman, Brian

Cite this document

Marković Peković, V., Škrbić, R., Petrović, A., Vlahović Palčevski, V., Mrak, J., Bennie, M. ... Godman, B. (2015). Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research, 16. (5), 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković, Vanda, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, no. 5, 2015, pp. 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, Vanda, Ranko Škrbić, Aleksandar Petrović, Vera Vlahović Palčevski, Jana Mrak, Marion Bennie, Joseph Fadare, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research 16, no. 5 (2015): 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, V., et al. (2015) 'Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future', Expert Review of Pharmacoeconomics & Outcomes Research, 16(5), pp. 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković V, Škrbić R, Petrović A, Vlahović Palčevski V, Mrak J, Bennie M, and sur.. Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research [Internet]. 2015 December 15 [cited 2024 May 05];16(5):609-618. doi: 10.1586/14737167.2016.1115347

V. Marković Peković, et al., "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future", Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, no. 5, pp. 609-618, December 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:499506. [Accessed: 05 May 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
AuthorVanda Marković-Peković
AuthorRanko Škrbić
AuthorAleksandar Petrović
AuthorVera Vlahović-Palčevski
AuthorJana Mrak
AuthorMarion Bennie
AuthorJoseph Fadare
AuthorHye-Young Kwon
AuthorKrijn Schiffers
AuthorIlse Truter
AuthorBrian Godman
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pharmacology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Pharmacology
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Public Health and Health Care
Family Medicine
Abstract (english)
The prescribing of medicines is a fundamental component of care for the elderly; however, there is increasing concern with polypharmacy and its impact on morbidity, mortality and costs. As a result, long-term prescription-medicine use and the prevalence of polypharmacy in the elderly in the Republic of Srpska were analyzed. The findings were subsequently used to suggest potential future measures. A retrospective study of all elderly patients during 2005-2010 stratified by age group (three groups), sex and long-term medicine use was performed. Polypharmacy (five or more medicines) increased from 1.4% of the elderly taking medicines long-term to 3.6% by 2010, with 53.6% of elderly taking two or more medicines long-term. The most prevalent diseases were cardiovascular diseases and diabetes. Most prescriptions were in accordance with recent guidelines; however, there was a concern with appreciable prescribing of digoxin and aminophylline. Whilst polypharmacy rates are low in the Republic, the increasing rate is a concern. Further studies are planned.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionAccepted version
Journal titleExpert Review of Pharmacoeconomics & Outcomes Research
Numberingvol. 16, no. 5, pp. 609-618
p-ISSN1473-7167
e-ISSN1744-8379
DOIhttps://doi.org/10.1586/14737167.2016.1115347
URN:NBNurn:nbn:hr:184:499506
Publication2015-12-15
Document URLhttps://www.tandfonline.com/doi/full/10.1586/14737167.2016.1115347
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-03-03 09:24:25